CD19-Targeted CAR Regulatory T Cells Suppress B Cell Pathology without GvHD

CD19-Targeted CAR Regulatory T Cells Suppress B Cell Pathology without GvHD

Posted by Adam Awdish on

Pooled Human AB Serum Plasma Derived from Innovative Research was used in the following study:

 

CD19-Targeted CAR Regulatory T Cells Suppress B Cell Pathology without GvHD

Yuki Imura, Makoto Ando, Taisuke Kondo, Minako Ito, and Akihiko Yoshimura

JCI Insight
July 23, 2020

Tregs suppress excess immunity responses against a variety of antigens, including self-antigens, bacteria–derived antigens, and environmental allergens. Thus, Tregs have been shown to play important roles in suppressing the development of allergies. In humans, some clinical trials of transfer of ex vivo expanded polyclonal Tregs have been performed to suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation and type 1 diabetes (T1D). Although the results of polyclonal Treg adoptive therapy are encouraging, many cells are necessary, and the risk of nonspecific immunosuppression should be considered. There are several strategies to generate antigen-specific Tregs, which indicate superior suppression of nonspecific or polyclonal Tregs for several diseases. In mice, in vitro generation of induced antigen-specific Tregs (iTregs) have been used to suppress GvHD, but methods for generating stabilized human iTregs have not yet been established. One way to create antigen-specific T cells is through chimeric antigen receptor (CAR) expression, which consists of an extracellular single chain antibody (scFv) fused to intracellular signaling domains in primary T cells. These CAR T cells have been successfully used in cancer treatment and are approved for treatment of patients with certain types of B cell lymphoma. CAR therapy is a way to facilitate interaction of Tregs with target cells and may be safer than conventional CAR T cells because of the low inflammatory effects and cytotoxicity of Tregs. Autoantibodies secreted from B cells are thought to induce various autoimmune diseases and IgG4-related diseases. Although one report used conventional CD19-targeted CAR (CD19-CAR) CD8+ T cells for the treatment of SLE in murine SLE models, there are no reports on the application of CD19-CAR Tregs for autoimmune B cell control. In this study, researchers demonstrated that CD19-CAR Tregs suppress the antibody production of B cells without harmful side effects such as GvHD. The adoptive transfer of CD19-CAR Tregs might provide a novel therapeutic method to treat autoantibody-mediated autoimmune diseases. Pooled Human AB Serum Plasma Derived from Innovative Research was used in this study.

 

Related products available from Innovative Research also include:

Single Donor Human Whole Blood

Single Donor Human Plasma (Blood Derived)

Pooled Human Complement Serum

Pooled Human Serum Off The Clot

  • Tags: Human Biological Fluids, Human Serum, Pooled Human AB Serum Plasma Derived

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Evaluation of Peptoid Mimics of Short, Lipophilic Peptide Antimicrobials
    Single Donor Human Red Blood Cells from Innovative Research was used in the following s...
    Read the Article
    An Autoantibody Profile Detects Brugada Syndrome and Identifies Abnormally Expressed Myocardial Proteins
    Single Donor Human Serum Off The Clot from Innovative Research was used in the followin...
    Read the Article
    Red Blood Cells and Lipoproteins: Important Reservoirs and Transporters of Polyphenols and Their Metabolites
    Innovative Grade US Origin Porcine Plasma from Innovative Research was used in the foll...
    Read the Article

    ← Older Post Newer Post →